AGMB
AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ · Healthcare · Biotechnology · BE
$15.78
+6.41%Institutional positioning
13F filings over the trailing two quarters
New 32Increased 0Reduced 0Sold out 32
| Filer | Action | Shares | Filed |
|---|---|---|---|
| EQT FUND MANAGEMENT S.A R.L. | New Position | 5,141,992 | May 14, 2026 |
| SANOFI | New Position | 2,783,096 | May 7, 2026 |
| CORMORANT ASSET MANAGEMENT, LP | New Position | 2,465,348 | May 15, 2026 |
| TCG CROSSOVER MANAGEMENT, LLC | New Position | 2,053,233 | May 15, 2026 |
| FEDERATED HERMES, INC. | New Position | 1,618,000 | May 11, 2026 |
| CASDIN CAPITAL, LLC | New Position | 1,550,000 | May 15, 2026 |
| ANDERA PARTNERS | New Position | 1,538,702 | May 11, 2026 |
| FMR LLC | New Position | 1,458,677 | May 15, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | New Position | 1,200,000 | May 15, 2026 |
| ABRDN PLC | New Position | 707,656 | Apr 29, 2026 |
| SAMSARA BIOCAPITAL, LLC | New Position | 600,000 | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | New Position | 600,000 | May 29, 2026 |
| SIREN, L.L.C. | New Position | 411,250 | May 14, 2026 |
| LMR PARTNERS LLP | New Position | 300,000 | May 15, 2026 |
| SEVEN GRAND MANAGERS, LLC | New Position | 200,000 | May 6, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings